|Bid||628.00 x 800|
|Ask||630.00 x 3100|
|Day's Range||624.00 - 660.00|
|52 Week Range||271.37 - 664.64|
|Beta (5Y Monthly)||0.57|
|PE Ratio (TTM)||31.37|
|Earnings Date||Nov 03, 2020 - Nov 09, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||643.83|
People got a kick out of what I said at the top of "Mad Money" on Tuesday night, that the buyers and sellers are sometimes so stupid that they make moves that a bag of hammers would know better to pass on. Remember, Livongo helps people with chronic conditions and there are nearly 147 million people with a chronic condition and 40% have two or more chronic conditions.
Regeneron topped second-quarter earnings and sales views. But the stock dipped on the news in morning trades Wednesday. The biotech giant is working on a number of coronavirus treatments.
Wall Street's main indexes rose on Wednesday following upbeat services industry survey and Disney's surprise quarterly profit, with sentiment aided by signs that a coronavirus fiscal relief package was imminent. White House negotiators on Tuesday vowed to work "around the clock" with congressional Democrats to try to reach a deal on the package by the end of this week.